On Tuesday, Shares of IMAX Corporation (USA) (NYSE:IMAX), gained 5.00% to $32.78.
IMAX Corporation, declared that IMAX China Holding, Inc., a Cayman Islands company and a partner of IMAX, filed a post-hearing information pack with the Hong Kong Stock Exchange in connection with its initial public offering. Comprised in the PHIP is a disclosure document with updated financials as of June 30, 2015.
IMAX Corporation, together with its auxiliaries, operates as an entertainment technology company specializing in motion picture technologies and presentations worldwide. The company operates in seven segments: IMAX Systems, Theater System Maintenance, Joint Revenue Sharing Arrangements, Film Production and IMAX Digital Re-Mastering (DMR), Film Distribution, Film Post-Production, and Other.
Shares of Capstone Turbine Corporation (NASDAQ:CPST), declined -0.68% to $0.351, during its last trading session.
Capstone Turbine Corporation, declared that it received an order for a C1000 dual mode Power Package to provide thermal and electrical power at a top-ranked, private Christian college in central Pennsylvania.
E-Finity Distributed Generation, Capstone’s distributor for the Mid-Atlantic and Southeastern United States, secured the order, which is predictable to be commissioned in summer 2016.
After switching to natural gas due to recent propane shortages in the area, the college needed a clean energy solution that would provide year-round electrical power to the campus center, and heating and cooling to various other campus buildings. Capstone microturbines were chosen for their fuel flexibility, low emissions and quiet operation. The on-site microturbine power plant is part of a long-term clean energy project to assist the college reduce its carbon footprint and meet its sustainability initiatives.
Capstone Turbine Corporation develops, manufactures, markets, and services microturbine technology solutions for use in stationary distributed power generation applications worldwide.
At the end of Tuesday’s trade, Shares of Sanofi SA (ADR) (NYSE:SNY), gained 0.08% to $49.76.
Sanofi, declared that the LixiLan-L Phase III clinical trial met its primary endpoint in patients with type 2 diabetes treated with insulin glargine with or without metformin. The fixed-ratio combination of insulin glargine 100 Units/mL and lixisenatide, a GLP-1 receptor agonist, demonstrated statistically superior reduction in HbA1c (average blood glucose over the previous three months) contrast with insulin glargine 100 Units/mL. Overall, the fixed-ratio combination had a safety profile reflecting those of insulin glargine 100 Units/mL and lixisenatide.
“This study examined an important possible use of this investigational medicine,” said Richard M Bergenstal MD, Executive Director, International Diabetes Center at Park Nicollet, Minneapolis, Minn., U.S. “The result highlights that this could provide a treatment option for the roughly fifty percent of patients who are no longer able to remain at their HbA1c target, despite basal insulin treatment.”
Sanofi researches, develops, and markets various therapeutic solutions. Its products comprise diabetes solutions, counting Lantus, Apidra, and Insuman that are human insulin analogs; Amaryl, an oral sulfonylurea; Lyxumia, a glucagon-like peptide-1 receptor agonist; and Afrezza, an inhaled insulin to improve glycemic control, in addition to Toujeo, an insulin glargine.
Finally, Lifelock Inc (NYSE:LOCK), ended its last trade with -1.52% loss, and closed at $ 9.06.
LifeLock, declared that Jamison Manwaring joined the company as Vice President of Investor Relations. Jamison served as an equity analyst for Goldman Sachs, where he assisted to launch coverage of companies in the security software space, counting LifeLock.
LifeLock Chief Financial Officer Chris Power said, “Jamison demonstrated his keen intelligence and analytical skills in his dealings with us and his thoughtful reporting as an analyst covering LifeLock, and we are proud to welcome him to our company. His understanding of our business, and the needs of our investors and analysts, make him a terrific addition to our team.”
LifeLock, Inc. provides identity theft protection services for consumers; and consumer risk administration services for enterprises in the United States. It protects consumer subscribers through monitoring identity-related events, such as new account openings and credit-related applications; and enterprise customers through delivering on-demand identity risk, identity authentication, and credit information about consumers.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
